- ►diabetesjournals.org JL Gross, MJ de Azevedo, SP Silveiro, LH Canani, … - Diabetes Care, 2005 - Am Diabetes Assoc Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement
therapy and affects ∼40% of type 1 and type 2 diabetic patients. It increases the risk of
death, mainly from cardiovascular causes, and is defined by increased urinary albumin ... Cited by 218 - Related articles - All 18 versions
- ►critcaremed.com M Burnier, A Zanchi - Journal of hypertension, 2006 - journals.lww.com Diabetes (particularly type 2 diabetes) represents a global health problem of epidemic
proportions. Individuals with diabetes are not only more likely to develop hypertension,
dyslipidemia, and obesity, but are also at a significantly higher risk for coronary heart ... Cited by 60 - Related articles - BL Direct - All 8 versions
G Derosa, AFG Cicero, G Bertone, MN Piccinni, E … - Clinical therapeutics, 2004 - Elsevier In this double-blind trial, patients taking oral hypoglycemic agents were randomized to receive
telmisartan 40 mg or nifedipine GITS 20 mg once daily for 12 months. At the time of
enrollment, patients were given advice on diet (1400–1600 kcal/d) and exercise ... Cited by 52 - Related articles - All 6 versions
- ►physiology.org J Ran, T Hirano, M Adachi - American Journal of Physiology- …, 2004 - Am Physiological Soc The effects of angiotensin II type 1 receptor blocker (ARB) on triglyceride (TG) metabolism associated
with insulin resistance were explored in Zucker fatty (ZF) rats. Olmesartan medoxomil, a newly
developed ARB, was given as a 0.01% drinking solution ad libitum to ZF and Zucker lean ( ... Cited by 41 - Related articles - BL Direct - All 4 versions
AJ Jenkins, KG Rowley, TJ Lyons, JD Best, … - Current …, 2004 - ingentaconnect.com AJ Jenkins 1,2,3, * , KG Rowley 1 , TJ Lyons 2,3 , JD Best 1 , MA Hill 2,4 and RL Klein 3 ... 1
University of Melbourne, Department of Medicine, St Vincent's Hospital, Melbourne,
Australia; ... Endocrinology, Metabolism and Hypertension, University of Oklahoma, ... Cited by 39 - Related articles - BL Direct - All 4 versions
- ►asnjournals.org R Trevisan, AR Dodesini, G Lepore - Journal of the American Society of …, 2006 - Am Soc Nephrol Chronic renal disease is accompanied by characteristic abnormalities of lipid metabolism, which
appear as a consequence of nephrotic syndrome or renal insufficiency and are reflected in an
altered apolipoprotein profile as well as elevated plasma lipid levels. Experimental and ... Cited by 30 - Related articles - BL Direct - All 4 versions
A Verma, KM Ranganna, RS Reddy, M Verma, NF … - The American journal of …, 2005 - Elsevier The purpose of this 20-week, open-label, randomized clinical trial was to evaluate the effect of
rosuvastatin on fasting serum lipids and lipoproteins, high-sensitivity C-reactive protein
(hs-CRP), and the glomerular filtration rate (GFR) in 91 patients with chronic kidney ... Cited by 24 - Related articles - All 11 versions
- ►librapharm.co.uk [PDF] HJ Milionis, E Rizos, M Kostapanos, TD … - Current Medical …, 2006 - informahealthcare.com Objectives: In a 24-week, open-label, randomized, parallel-group study, we compared the efficacy
and metabolic effects, beyond low density lipoprotein cholesterol (LDL-C)-lowering, of atorvastatin
(ATV) and rosuvastatin (RSV) in cardiovascular disease- free subjects with primary ... Cited by 20 - Related articles - BL Direct - All 9 versions
- ►mac.com [PDF] KJ Evans, A Greenberg - Journal of Intensive Care Medicine, 2005 - jic.sagepub.com Potassium is the principal intracellular cation, and main- tenance of the distribution of potassium
between the intracellular and the extracellular compartments relies on several homeostatic
mechanisms. When these mecha- nisms are perturbed, hypokalemia or hyperkalemia ... Cited by 18 - Related articles - BL Direct - All 3 versions
